Cancer Progress started in 1989 with the goal of facilitating discussions of scientific progress in Oncology from a development, regulatory, clinical, commercial and investment lens. Cancer Progress features provocative, informative panel discussions with pivotal topics, frank discussions, vigorous debates, and audience engagement to enable meaningful connections and meetings with innovators, developers, and investors.
We are thrilled to announce that on April 9, 2026, Cancer Progress returns as a live, in-person event in the heart of New York City! This streamlined, one-day conference promises a focused and impactful experience. Attendees can expect unparalleled insights, in-depth issue coverage, and exceptional networking opportunities. The conference’s enduring success and value are driven by the expertise and reputation of its distinguished speaking faculty.
In addition to delivering high-quality content and connections, this year’s Cancer Progress will make a lasting impact beyond the conference walls. All proceeds from ticket sales and sponsorships will be directed to support cancer research through dedicated charitable partners, including Damon Runyon Cancer Research Foundation and Conquer Cancer.
By joining us, you’re not only advancing your professional network and knowledge, but also directly contributing to the fight against cancer.